RVTY.NYSERevvity, INC

Form 4: Revvity Executive Tajinder S. Vohra Executes Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Tajinder S. Vohra, a Senior Vice President at Revvity, Inc., exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

  • On January 7, 2025, Tajinder S. Vohra, a Senior Vice President at Revvity, Inc., exercised a non-qualified stock option to acquire 5,492 shares of common stock at a price of $81.29 per share.
  • Vohra then sold 2,430 shares at a weighted average price of $116.13, 2,388 shares at $117.14, 474 shares at $117.79, and 200 shares at $118.92.
  • These sales were executed under a 10b5-1 trading plan adopted on June 7, 2024.
  • Following these transactions, Vohra directly owns 19,652 shares of Revvity common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports routine transactions. The use of a 10b5-1 plan suggests a proactive approach to compliance, which is mildly positive.

Positives

  • The transactions were executed under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company executives. It is common for executives to utilize 10b5-1 trading plans to manage their stock holdings and avoid potential accusations of insider trading.

Comparison to Industry Standards

  • Executive stock option exercises and sales are common across publicly traded companies, particularly in the technology and healthcare sectors.
  • Companies like Thermo Fisher Scientific, Danaher, and Agilent Technologies, which are Revvity's peers, also see similar filings from their executives.
  • The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

DateDescription
06/07/2024Date of adoption of the 10b5-1 trading plan.
01/07/2025Date of option exercise and stock sales.
01/08/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.